Elanco Animal Health Incorporated (ELAN) vs Takeda Pharmaceutical Co. (TAK)
- Elanco Animal Health Incorporated ELAN 23.55 +0.04%
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
Elanco Animal Health Incorporated and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $11.8B — 5.3× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Takeda Pharmaceutical Co. trades at 29.6×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs −3.96%) and the higher return on invested capital (2.88% vs 0.51%). Across the 20 metrics below, Takeda Pharmaceutical Co. leads on 14 and Elanco Animal Health Incorporated on 6.
Valuation
Profitability
| Metric | ELAN | TAK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 65.85% | 53.94% |
| Operating margin | 1.61% | 11.61% | 0.00% |
| Net margin | (3.96%) | 7.12% | 0.00% |
| Free cash flow margin | 7.55% | 24.74% | 0.00% |
| Return on equity | (2.98%) | 4.42% | (0.40%) |
| Return on assets | (1.46%) | 2.15% | (3.32%) |
| Return on invested capital | 0.51% | 2.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack